Increased prevalence of impulse control disorder symptoms in endocrine diseases treated with dopamine agonists: a cross-sectional study

INTRODUCTION: Impulse control disorders (ICDs) have been described as a side effect of dopamine agonists (DAs) in neurological as well as endocrine conditions. Few studies have evaluated the neuropsychological effect of DAs in hyperprolactinemic patients, and these have reported a relationship betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Beccuti, G., Guaraldi, F., Natta, G., Cambria, V., Prencipe, N., Cicolin, A., Montanaro, E., Lopiano, L., Ghigo, E., Zibetti, M., Grottoli, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285332/
https://www.ncbi.nlm.nih.gov/pubmed/33314003
http://dx.doi.org/10.1007/s40618-020-01478-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285332/
https://www.ncbi.nlm.nih.gov/pubmed/33314003
http://dx.doi.org/10.1007/s40618-020-01478-0

Ejemplares similares